Kesin Pharma announces FDA approval and availability of Likmez oral suspension
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
The collaboration brings a seamless digital experience to more formulators worldwide
This product will be manufactured at Lupin’s Pithampur facility in India
PhytoSquene now available for clinical and commercial use
This product will be manufactured at Lupin's Nagpur facility in India
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
Lupin enters into BTA with Lupin Manufacturing Solutions
The composition of ORAAL is protected by a granted patent in India until November 2033
Subscribe To Our Newsletter & Stay Updated